eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2014
vol. 9
 
Share:
Share:
more
 
 
abstract:
Review paper

Dietary recommendations for patients with nonalcoholic fatty liver disease

Angelika Kargulewicz, Hanna Stankowiak-Kulpa, Marian Grzymisławski

Prz Gastroenterol 2014; 9 (1): 18–23
Online publish date: 2014/03/01
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Changes to patients’ lifestyle, especially a modified dietary approach, play a key role in the treatment of nonalcoholic fatty liver disease (NAFLD). A balanced, limiting and individually tailored nutritional scheme enables weight loss and an improvement in the clinical picture of NAFLD. According to nutritional recommendations for patients with NAFLD, carbohydrates should comprise 40–50% of total dietary energy. It is advisable to increase the amount of complex carbohydrates rich in dietary fibre. A major role in the aetiology of NAFLD is played by excessive intake of fructose, which is related to the rise in consumption of nonalcoholic beverages among subjects in developed countries. Fat intake should comprise < 30% of daily calories. It is essential to increase consumption of food products rich in mono- and polyunsaturated fatty acids. Ingestion of protein should constitute 15–20% of total energy.
keywords:

nonalcoholic fatty liver disease, diet, dietary recommendations

references:

York LW, Puthalapattu S, Wu GY. Nonalcocholic fatty liver disease and low-carbohydrate diets. Annu Rev Nutr 2009; 29: 365-79.

Bellentani S, Grave RD, Suppini A. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology 2008; 47: 746-54.

Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006; 82: 315-22.

Dudzik D, Knaś M, Borzym-Kluczyk M, et al. Nonalcoholic steatohepatitis (NASH) – pathogenesis, diagnosis, treatment [Polish]. Med Sci Hepatol 2008; 8: 48-58.

Raszeja-Wyszomirska J, Ławniczak M, Marlicz W, et al. Nonalcoholic fatty liver disease (NAFLD) – new insight [Polish]. Pol Merkuriusz Lek 2008; 24: 568-71.

Jarosz M, Respondek W. Dietary recommendations and lifestyle [Polish]. In: Nonalcoholic fatty liver disease. Jarosz M (ed.) PZWL, Warsaw 2010; 45-56.

Bayol SA, Simbi BH, Fowkes RC. A maternal “junk food” diet in pregnancy and lactation promotes nonalcoholic fatty liver disease in rat offspring. Endocrinology 2010; 151: 1451-61.

Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 2007; 86: 285-300.

Gentile CL, Pagliassotti MJ. The role of fatty acids in the development and progression oh nonalcoholic fatty liver disease.
J Nutr Biochem 2008; 19: 567-76.

Assy N, Nassar F, Nasser G, et al. Olive oil consumption and non-alcoholic fatty liver disease. World J Gastroenterology 2009; 15: 1809-15.

Vos MB, McClein CJ. Nutrition and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep 2008; 10: 308-15.

Leclercq IA, Horsmans Y. Nonalcoholic fatty liver disease: the potential role of nutrition management. Curr Opin Clin Nutr Metab Care 2008; 11: 766-73.

Byrne C, Olufadi R, Bruce KD. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci 2009; 116: 539-64.

Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liv Dis 2008; 40: 194-9.

Pickova J. Importance of knowledge on lipid composition of foods to support development towards consumption of higher levels of n-3 fatty acids via freshwater fish. Physiol Res 2009; 58: 39-45.

Moschen AR, Tilg H. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2008; 11: 620-5.

Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16: 2579-88.

Dhingra R, Sullivan L, Jacques PF. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in community. Circulation 2007; 116: 480-8.

Abid A, Taha O, Nseir W. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
J Hepatol 2009; 51: 918-24.

Le KA, Bortolotti M. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2008; 11: 477-82.

Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009; 89: 1751-9.

Cani PD, Knauf C, Iglesias MA. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006; 55: 1484-90.

Arciero PJ, Gentile CL, Pressman R, et al. Moderate protein intake improves total and regional body composition and insulin sensitivity in overweight adults. Metabolism 2008; 57: 757-65.

Krishna VN, Karthika D, Surya DM, et al. Analysis of monosodium l-glutamate in food products by high-performance thin layer chromatography. J Young Pharm 2010; 2: 297-300.

Gertig H, Duda G. Allowed substances added to food products [Polish]. In: Law in a food industry. Grtig H, Duda G (eds.). PZWL, Warsaw 2004; 209-10.

Collison KS, Maqbool Z, Inglis AL, et al. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J Lipid Res 2009; 50: 1521-37.

Nimatha MW, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48: 104-12.

Ciborowska H. Low-calorie diet [Polish]. In: Dietetics. Nutritional therapy for healthy and ill patients. Ciborowska H, Rudnicka A (eds.). PZWL, Warsaw 2007; 280-9.

Loria P, Adinolfi LE, Bellentani S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. Dig Liv Dis 2010; 42: 272-82.

Ciborowska H, Rudnicka A. Nutrition of human with elements of biochemistry [Polish]. In: Dietetics. Nutritional therapy for healthy and ill patients. Ciborowska H, Rudnicka A (eds.). PZWL, Warsaw 2007; 280-9.

Fołta M, Bartoń H, Paśko P, et al. Oxidative stress and metabo-
lic disturbances in a high-fructose rat model [Polish]. Bromat Chem Toksykol 2009; 3: 842-7.

Raszeja-Wyszomirska J, Safranow K, Szynkowska A. Secretory phospholipase A2 activity is linked to hipercholesterolemia and gender in non-alcoholic fatty liver disease individuals. Prz Gastroenterol 2013; 8: 172-5.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe